Asia
Label-free, 3-D holotomography imaging enables researchers to observe morphological and chemical alterations of host cells without transfection or dye staining
D&D Pharmatech is the parent company of U.S.-based Neuraly, Precision Molecular and Theraly Fibrosis. All three are spinouts from Johns Hopkins School of Medicine.
Great Bay Bio, a leading AI biotechnology company dedicated to big data-driven CMC development of innovative biologics, is pleased to announce the establishment of its 3D Advisory Board.
Researchers from Singapore and the United States are focused on a novel drug candidate with marine origins as a new method to prevent or treat vision loss.
Researchers from A*STAR’s Institute of Bioengineering and Nanotechnology have successfully developed an innovative nanocarrier derived from green tea catechins, which can deliver anti-cancer drugs in a targeted and effective fashion.
Dr. Leon previously played a key role in establishing and leading Quest Diagnostics’ Molecular Diagnostics laboratories.
Cyclone® 70 will be used as a high energy, high intensity proton “driver” for a large science project for rare isotopes
Sosei Group Corporation inked a strategic multi-target partnership with Takeda Pharmaceutical to find, develop and commercialize small molecules and biologics that modulate G protein-coupled receptor targets. The initial focus will be on gastrointestinal targets.
The approval is for only “select” patients where surgery isn’t an option. It also comes with a Boxed Warning for liver toxicity, which has been a problem in several clinical trials with the drug.
FUJIFILM Corporation announced that it has completed the acquisition of Biogen Manufacturing ApS, a large-scale biologics manufacturing site located in Hillerød near Copenhagen, Denmark from Biogen.
PRESS RELEASES